Retinoid Metabolism and ALDH1A2 (RALDH2) Expression Are Altered in the Transgenic Adenocarcinoma Mouse Prostate Model

Biochemical Pharmacology - Netherlands
doi 10.1016/j.bcp.2009.06.022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Lobe-Specific Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mouse Model

2013English

Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer

American Journal of Pathology
Forensic MedicinePathology
2008English

Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model

Cancer Research
Cancer ResearchOncology
2004English

Prostate Specific Expression of Maspin in a Transgenic Mouse Model: Implications in Prostate Carcinogenesis

2004English

OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model

Cancer Research
Cancer ResearchOncology
2008English

Differential Requirement for Focal Adhesion Kinase Signaling in Cancer Progression in the Transgenic Adenocarcinoma of Mouse Prostate Model

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Extra-Prostatic Transgene-Associated Neoplastic Lesions in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2014English

Altered Metabolic Gene Expression in the Brain of a Triprolyl-Human Amylin Transgenic Mouse Model of Type 2 Diabetes

Scientific Reports
Multidisciplinary
2019English

Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma

Analytical Cellular Pathology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy